Coro Plc Debt/Equity
What is the Debt/Equity of Coro Plc?
The Debt/Equity of Coro Energy Plc is -5.26
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Energy sector on LSE compared to Coro Plc
What does Coro Plc do?
Coro Energy plc engages in the exploration, development, and production of oil and natural gas in South East Asia. Its asset portfolio is situated in the west Natuna basin, offshore Indonesia. The company was formerly known as Saffron Energy Plc and changed its name to Coro Energy plc in April 2018. The company was incorporated in 2016 and is based in Leeds, the United Kingdom.
Companies with debt/equity similar to Coro Plc
- Inspired Entertainment Inc has Debt/Equity of -5.37
- Real Good Food plc has Debt/Equity of -5.37
- CareRx has Debt/Equity of -5.36
- Pixium Vision SA has Debt/Equity of -5.34
- AutoZone has Debt/Equity of -5.32
- Jason Industries has Debt/Equity of -5.26
- Coro Plc has Debt/Equity of -5.26
- CytomX Therapeutics Inc has Debt/Equity of -5.25
- Euromax Resources has Debt/Equity of -5.24
- Sakthi Sugars has Debt/Equity of -5.23
- Deep Lake Capital Acquisition has Debt/Equity of -5.22
- Basilea Pharmaceutica AG has Debt/Equity of -5.22
- Dare Bioscience Inc has Debt/Equity of -5.22